Literature DB >> 8969284

Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients.

T Linn1, K Ortac, H Laube, K Federlin.   

Abstract

Optimal blood glucose levels and normal insulin sensitivity are aims in the treatment of insulin-dependent diabetes mellitus (IDDM). Insulin sensitivity and insulin reserve are closely interrelated. It is essential to know more about both of these parameters at clinical diagnosis, because their preservation may delay the occurrence of diabetes-related complications. B-cell function is likely to be retained for a longer period in patients with adult onset of the disease compared with children. In this study, intensive insulin treatment was initiated in newly diagnosed adult patients to determine if it preserved endogenous insulin secretion longer than conventional therapy. Forty-nine patients with newly diagnosed diabetes were carefully categorized as having IDDM according to clinical and serological criteria. They were randomized to an intensive (I group) or conventional (C group) insulin therapy and evaluated for 5 years. Every 6 months, a check-up included glucagon-stimulated C-peptide (GSCP), hyperglycemic glucose clamp with arginine bolus, euglycemic-hyperinsulinemic clamp, and screening for microalbuminuria, retinopathy, and neuropathy. At the end of the study, hemoglobin A1c (HbA1c) was 6.3% +/- 1.9% in the I patients and 8.1% +/- 2.1% in the C patients (P < .001). Blood glucose concentrations less than 3.5 mmol/L were more frequent in the I group than in the C group (P < .05). Insulin sensitivity (M/I) and GSCP were higher in intensively treated patients after 5 years (M/I, I group 40 +/- 10 nmol x kg(-1) x min(-1) x pmol/L1 v C group 21 +/- 11, P < .005; GSCP, I group 0.6 +/- 0.2 nmol/L v C group 0.19 +/- 0.11, P < .005). The prevalence of peripheral neuropathy was significantly lower in the I group at the end of the study. In conclusion, intensive therapy is more effective in the preservation of insulin action and reserve. In our patients, no case of severe hypoglycemia was observed, indicating that intensive therapy was safe in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969284     DOI: 10.1016/s0026-0495(96)90180-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  21 in total

Review 1.  Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

Authors:  Anna Grisold; Brian C Callaghan; Eva L Feldman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-04       Impact factor: 3.243

Review 2.  Diabetic neuropathy: clinical manifestations and current treatments.

Authors:  Brian C Callaghan; Hsinlin T Cheng; Catherine L Stables; Andrea L Smith; Eva L Feldman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

Review 3.  New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.

Authors:  Eva L Feldman; Klaus-Armin Nave; Troels S Jensen; David L H Bennett
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

Review 4.  Antigen-based vaccination and prevention of type 1 diabetes.

Authors:  Leonard C Harrison; John M Wentworth; Yuxia Zhang; Esther Bandala-Sanchez; Ralph M Böhmer; Alana M Neale; Natalie L Stone; Gaetano Naselli; Julian J Bosco; Priscilla Auyeung; Maryam Rashidi; Petra Augstein; Grant Morahan
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 5.  Diabetic neuropathy: one disease or two?

Authors:  Brian C Callaghan; Junguk Hur; Eva L Feldman
Journal:  Curr Opin Neurol       Date:  2012-10       Impact factor: 5.710

6.  Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat.

Authors:  Kyung Ae Lee; Na Young Lee; Tae Sun Park; Heung Yong Jin
Journal:  Endocrine       Date:  2018-05-07       Impact factor: 3.633

Review 7.  Interventions for latent autoimmune diabetes (LADA) in adults.

Authors:  Sinead Brophy; Helen Davies; Sopna Mannan; Huw Brunt; Rhys Williams
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

8.  Assessment of insulin sensitivity in adults with permanent neonatal diabetes mellitus due to mutations in the KCNJ11 gene encoding Kir6.2.

Authors:  Jan Skupien; Maciej T Malecki; Wojciech Mlynarski; Tomasz Klupa; Krzysztof Wanic; Agnieszka Gach; Iwona Solecka; Jacek Sieradzki
Journal:  Rev Diabet Stud       Date:  2006-05-10

9.  Metformin attenuates increase of synaptic number in the rat spinal dorsal horn with painful diabetic neuropathy induced by type 2 diabetes: a stereological study.

Authors:  Jing-Yan Lin; Yi-Na He; Na Zhu; Bin Peng
Journal:  Neurochem Res       Date:  2018-10-10       Impact factor: 3.996

Review 10.  Brain changes in diabetes mellitus patients with gastrointestinal symptoms.

Authors:  Anne M Drewes; Eirik Søfteland; Georg Dimcevski; Adam D Farmer; Christina Brock; Jens B Frøkjær; Klaus Krogh; Asbjørn M Drewes
Journal:  World J Diabetes       Date:  2016-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.